Daisaku Masuda

发表

Very High Levels of High-Density Lipoprotein Cholesterol and Cardiovascular Events in Japanese Population.

S. Yamashita, D. Masuda, Daisaku Masuda, 2016, Journal of atherosclerosis and thrombosis.

Cholesterol Absorption Inhibitor Ezetimibe: Risk–Benefits and Role in Treating Dyslipidemias

S. Yamashita, A. Matsuyama, Daisaku Masuda, 2015 .

Postprandial Hyperlipidemia and Remnant Lipoproteins

S. Yamashita, D. Masuda, Daisaku Masuda, 2017, Journal of atherosclerosis and thrombosis.

Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT

S. Yamashita, Y. Matsuzawa, T. Kita, 2021, Journal of atherosclerosis and thrombosis.

New Horizons for Probucol, an Old, Mysterious Drug

S. Yamashita, Y. Matsuzawa, D. Masuda, 2020, Journal of atherosclerosis and thrombosis.

Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice.

S. Yamashita, I. Komuro, M. Nishida, 2010, Journal of atherosclerosis and thrombosis.

Current therapy for patients with sitosterolemia--effect of ezetimibe on plant sterol metabolism.

S. Yamashita, M. Nishida, T. Ohama, 2010, Journal of atherosclerosis and thrombosis.

CD36 is essential for endurance improvement, changes in whole‐body metabolism, and efficient PPAR‐related transcriptional responses in the muscle with exercise training

S. Matsumura, Kazuo Inoue, D. Masuda, 2017, Physiological reports.

Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages.

Masaki Tanaka, S. Yamashita, I. Shimomura, 2007, Journal of lipid research.

Clinical features and visual function in a patient with Fish-eye disease: Quantitative measurements and optical coherence tomography

K. Nishida, S. Koh, D. Masuda, 2018, American journal of ophthalmology case reports.

Apolipoprotein B-48 to triglyceride ratio is a novel and useful marker for detection of type III hyperlipidemia after antihyperlipidemic intervention.

S. Yamashita, I. Komuro, M. Nishida, 2012, Journal of atherosclerosis and thrombosis.

Differential reactivities of four homogeneous assays for LDL-cholesterol in serum to intermediate-density lipoproteins and small dense LDL: comparisons with the Friedewald equation.

S. Yamashita, M. Nishida, M. Ishigami, 2009, Clinica chimica acta; international journal of clinical chemistry.

Aggregated Ursolic Acid, a Natural Triterpenoid, Induces IL-1β Release from Murine Peritoneal Macrophages: Role of CD361

S. Yamashita, Y. Ikeda, A. Murakami, 2007, The Journal of Immunology.

Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.

S. Yamashita, I. Komuro, M. Nishida, 2010, Journal of atherosclerosis and thrombosis.

Chapter 1 – Molecular Mechanisms of Hyperalphalipoproteinemia

S. Yamashita, T. Ohama, D. Masuda, 2017 .

Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages.

S. Kihara, S. Yamashita, I. Shimomura, 2008, Biochemical and biophysical research communications.

Impaired efflux of cholesterol from aged cells and its molecular mechanism: A basis for age‐related enhancement of atherosclerosis

S. Yamashita, I. Shimomura, M. Nishida, 2007 .

Myocardial energy provision is preserved by increased utilization of glucose and ketone bodies in CD36 knockout mice.

S. Yamashita, T. Watabe, M. Imaizumi, 2015, Metabolism: clinical and experimental.

Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate

S. Yamashita, H. Arai, E. Araki, 2021, Journal of atherosclerosis and thrombosis.

Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography

S. Yamashita, A. Hirayama, A. Kiyosue, 2020, Journal of atherosclerosis and thrombosis.

Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency

S. Yamashita, Y. Sakata, M. Nishida, 2018, PloS one.

Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography.

S. Yamashita, I. Komuro, Y. Monden, 2012, Metabolism: clinical and experimental.

Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction

S. Yamashita, M. Nishino, Hiroyasu Kato, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study

S. Yamashita, H. Daida, H. Arai, 2021, Journal of atherosclerosis and thrombosis.

Accelerated Atherogenicity in Tangier Disease

S. Yamashita, Y. Matsuzawa, M. Nishida, 2018, Journal of atherosclerosis and thrombosis.

Combination of Neutrophil‐to‐Lymphocyte and Platelet‐to‐Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study

S. Yamashita, R. Shutta, S. Hikoso, 2022, Journal of the American Heart Association.

Clinical trajectories and outcomes of patients with heart failure with preserved ejection fraction with normal or indeterminate diastolic function

M. Nishino, Hiroyasu Kato, R. Shutta, 2022, Clinical Research in Cardiology.

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction

S. Yamashita, M. Nishino, Hiroyasu Kato, 2022, ESC Heart Failure.

Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-α secretion in Abca1-deficient macrophagess⃞ Published, JLR Papers in Press, November 7, 2006.

Masaki Tanaka, S. Yamashita, I. Shimomura, 2007, Journal of Lipid Research.

Expression of CD36 by Olfactory Receptor Cells and Its Abundance on the Epithelial Surface in Mice

T. Iwanaga, S. Yamashita, S. Matsumura, 2015, PloS one.

Title Expression of CD 36 by Olfactory Receptor Cells and ItsAbundance on the Epithelial Surface in Mice

T. Iwanaga, S. Yamashita, S. Matsumura, 2019 .

Evaluation of a homogeneous assay for measuring LDL-cholesterol in hyperlipidemic serum specimens.

S. Yamashita, I. Shimomura, M. Nishida, 2008, Journal of atherosclerosis and thrombosis.

Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State

S. Yamashita, S. Yokoyama, T. Miida, 2017, Journal of atherosclerosis and thrombosis.

CD36 involvement in the olfactory perception of oleic aldehyde, an odour-active volatile compound, in mice.

S. Yamashita, Kazuo Inoue, Takahiko Amitsuka, 2017, Biomedical research.

A role of CD36 in the perception of an oxidised phospholipid species in mice.

S. Yamashita, Kazuhiro Sakamoto, S. Matsumura, 2015, Biomedical research.

CD36, but not GPR120, is required for efficient fatty acid utilization during endurance exercise

S. Yamashita, S. Matsumura, Kazuo Inoue, 2014, Bioscience, biotechnology, and biochemistry.

Current Diagnosis and Management of Primary Chylomicronemia

H. Daida, K. Matsuki, S. Yokoyama, 2021, Journal of atherosclerosis and thrombosis.

Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases.

S. Yamashita, I. Komuro, M. Nishida, 2012, Journal of atherosclerosis and thrombosis.

Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study

S. Yamashita, H. Daida, H. Arai, 2021, Journal of atherosclerosis and thrombosis.

Senescent phenotypes of skin fibroblasts from patients with Tangier disease.

S. Yamashita, I. Shimomura, M. Hori, 2007, Biochemical and biophysical research communications.

Adiponectin deficiency suppresses ABCA1 expression and ApoA‐I synthesis in the liver

S. Kihara, S. Yamashita, I. Shimomura, 2007 .

Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver.

S. Kihara, S. Yamashita, I. Shimomura, 2007, Biochemical and biophysical research communications.

Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.

S. Kihara, S. Yamashita, I. Shimomura, 2008, FEBS letters.

Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations.

S. Yamashita, I. Shimomura, N. Sakane, 2009, Journal of atherosclerosis and thrombosis.

Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis

S. Yamashita, M. Rizzo, T. Su, 2023, Metabolites.

Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases

S. Yamashita, Y. Matsuzawa, D. Masuda, 2020, Current Atherosclerosis Reports.

Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice.

S. Yamashita, I. Komuro, M. Nishida, 2013, Cardiovascular research.

Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease.

S. Yamashita, Y. Matsuzawa, M. Matsuzaki, 2016, Journal of atherosclerosis and thrombosis.

Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein

S. Yamashita, Y. Sakata, M. Nishida, 2020, Journal of atherosclerosis and thrombosis.

Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)

S. Yamashita, Y. Matsuzawa, M. Matsuzaki, 2020, Journal of atherosclerosis and thrombosis.

Did we abandon probucol too soon?

S. Yamashita, Y. Matsuzawa, D. Masuda, 2015, Current opinion in lipidology.

Probucol Enhances the Expression of Human Hepatic Scavenger Receptor Class B Type I, Possibly Through a Species-Specific Mechanism

S. Yamashita, I. Shimomura, T. Maruyama, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)

S. Kihara, S. Yamashita, Y. Sakata, 2017, Journal of atherosclerosis and thrombosis.

Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin

S. Yamashita, D. Masuda, Daisaku Masuda, 2020, Journal of atherosclerosis and thrombosis.

Association between Familial Hypercholesterolemia and Serum Levels of Cholesterol Synthesis and Absorption Markers: The CACHE Study FH Analysis

S. Yamashita, Y. Kihara, K. Matsuki, 2023, Journal of atherosclerosis and thrombosis.

Correlation of fasting serum apolipoprotein B‐48 with coronary artery disease prevalence

S. Yamashita, I. Komuro, M. Nishida, 2012, European journal of clinical investigation.

Progranulin deficiency leads to enhanced age-related cardiac hypertrophy through complement C1q-induced β-catenin activation.

S. Yamashita, Y. Sakata, M. Nishida, 2019, Journal of molecular and cellular cardiology.

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study

S. Yamashita, H. Daida, H. Arai, 2021, Journal of atherosclerosis and thrombosis.

Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study.

S. Yamashita, D. Masuda, Yuko Miyata, 2019, Atherosclerosis.

Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction

S. Yamashita, Y. Sakata, M. Nishida, 2019, Journal of atherosclerosis and thrombosis.

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia

S. Yamashita, T. Okamura, H. Arai, 2020, Journal of atherosclerosis and thrombosis.

Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency.

S. Yamashita, Y. Sakata, M. Nishida, 2019, Journal of clinical lipidology.

Clinical Characteristics of Homozygous Familial Hypercholesterolemia in Japan

S. Yamashita, K. Matsuki, T. Miida, 2023, JACC. Asia.

Cultural Barriers in the Treatment of Dyslipidemia: A Survey of Japanese Physician Attitudes

S. Yamashita, Y. Matsuzawa, H. Arai, 2019, Journal of atherosclerosis and thrombosis.

Effects of Phenotypic and Genotypic Factors on the Lipid Responses to Niacin in Chinese Patients With Dyslipidemia

S. Yamashita, B. Tomlinson, V. Lee, 2015, Medicine.

Profile Rationale and Design of the PROSPECTIVE Trial : Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease

S. Yamashita, Y. Matsuzawa, M. Matsuzaki, 2016 .

Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia

S. Yamashita, M. Nishida, M. Ishigami, 2009, European journal of clinical investigation.

patient-oriented and epidemiological research Chylomicron remnants are increased in the postprandial state in CD36 deficiency

M. Nishida, M. Ishigami, K. Hirano, 2009 .

Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels.

S. Yamashita, I. Komuro, Y. Monden, 2011, Atherosclerosis.

Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia

S. Yamashita, B. Tomlinson, D. Masuda, 2015, Disease markers.

Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients

S. Yamashita, Yoshiya Tanaka, D. Masuda, 2017, Journal of diabetes investigation.

Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases

S. Yamashita, Y. Matsuzawa, D. Masuda, 2019, Journal of atherosclerosis and thrombosis.

Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease.

S. Yamashita, I. Komuro, M. Nishida, 2012, Journal of atherosclerosis and thrombosis.

Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice.

S. Yamashita, I. Komuro, M. Nishida, 2013, Cardiovascular research.

Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients

W. Chu, S. Yamashita, Defeng Wang, 2012, Journal of Lipid Research.

Serum Values of Cholesterol Absorption and Synthesis Biomarkers in Japanese Healthy Subjects: The CACHE Study HEALTHY Analysis

S. Yamashita, Y. Kihara, K. Matsuki, 2023, Journal of atherosclerosis and thrombosis.

Relationship between Diabetes Mellitus and Serum Lathosterol and Campesterol Levels: The CACHE Study DM Analysis

S. Yamashita, Y. Kihara, K. Matsuki, 2022, Journal of atherosclerosis and thrombosis.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

G. Francis, Qian Wang, D. Gaudet, 2021, Lancet.

The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction

M. Nishino, Hiroyasu Kato, R. Shutta, 2024, Scientific reports.

Distal protection during primary coronary intervention can preserve the index of microcirculatory resistance in patients with acute anterior ST-segment elevation myocardial infarction.

S. Yamashita, Hirotaka Sawano, Tomoaki Natsukawa, 2011, Circulation journal : official journal of the Japanese Circulation Society.

Immunohistochemical localization of fatty acid transporters and MCT1 in the sebaceous glands of mouse skin.

T. Iwanaga, S. Yamashita, Kazuo Inoue, 2016, Biomedical research.

Pressure Overload Impairs Cardiac Function in Long-Chain Fatty Acid Transporter CD36-Knockout Mice.

S. Yamashita, I. Komuro, Y. Sakata, 2019, International heart journal.